Novavax once rose more than 25%, reaching a new intraday high since November 2022 of $22.24. On May 10th and 13th, the company's stock price rose 98.66% and 47.64% respectively (taking advantage of the opportunity of retail investors to hold stocks). CureVac ADR rose more than 13% at one point. Moderna also rose about 5.1%, and BioNTech ADR rose about 1.7%. Pfizer has erased about 1.1% of its morning losses and is currently roughly flat. An FDA advisory panel met to discuss issues related to the formulation of the upcoming COVID-19 vaccine.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.